angiotensin ii has been researched along with Lung Injury, Acute in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (6.90) | 29.6817 |
| 2010's | 16 (55.17) | 24.3611 |
| 2020's | 11 (37.93) | 2.80 |
| Authors | Studies |
|---|---|
| An, J; Asaka, MN; Chan, CC; Chan, JF; Fujino, Y; Hoshizaki, M; Imai, M; Imai, Y; Kamada, H; Kamitani, W; Kawaoka, Y; Kiso, M; Kuba, K; Maeda, K; Minato, T; Motoyama, S; Nagata, S; Niiyama, M; Nirasawa, S; Nukiwa, R; Penninger, JM; Poon, VK; Saku, A; Takahashi, S; Uda, A; Utsumi, D; Yamaguchi, T; Yasuhara, A; Yasutomi, Y; Yuen, KY | 1 |
| Ju, Y; Wu, Y; Yang, X; Zhao, F | 1 |
| Chen, C; Jiang, X; Jiang, Y; Jiang, Z; Liu, G; Mao, L; Qin, X; Qiu, F; Qiu, J; Zhang, J; Zhang, L; Zhang, Y; Zou, Z | 1 |
| An, J; Hoshizaki, M; Imai, Y; Kuba, K; Minato, T; Nirasawa, S; Penninger, JM; Takahashi, S; Yamaguchi, T | 1 |
| Derde, LPG; Lawler, PR; McVerry, BJ; Russell, JA; van de Veerdonk, FL | 1 |
| Bellomo, R; Garcia, B; Legrand, M; Zarbock, A | 1 |
| Aboulkhair, AG; El-Sayed, LA; Mehesen, MN; Omar, AI; Osama, E; Rashed, LA; Shams Eldeen, AM | 1 |
| Battistoni, A; Volpe, M | 1 |
| Barakat, AG; Bezdicek, T; Chipman, JG; Ingraham, NE; Puskarich, MA; Reilkoff, R; Schacker, T; Tignanelli, CJ | 1 |
| Gao, F; Hu, X; Jin, SW; Li, M; Lu, JC; Lu, SY; Wang, Q; Yang, JX; Zheng, SX | 1 |
| Cohen, JB; Edmonston, DL; South, AM; Sparks, MA | 1 |
| Chang, J; Dai, F; Hu, Z; Li, B; Liu, H; Ren, W; Ruan, Y; Wang, Z; Wu, Z | 1 |
| Chen, J; Luo, Q; Xu, J; Yang, J; Zhang, H; Zhang, Q | 1 |
| Li, PS; Luo, Y; Shu, YS; Tao, W; Tao, YZ; Xu, G; Yang, LQ | 1 |
| Li, SM; Liu, F; Wang, XY; Yang, XH | 1 |
| Chen, QF; Hao, H; Huang, YH; Kuang, XD; Yuan, QF; Zhang, T; Zhou, XY | 1 |
| Chen, Q; Huang, F; Liu, J; Liu, S; Yang, X; Zhang, Y | 1 |
| Chen, LN; Yang, XH | 1 |
| Chen, Q; Huang, Y; Liu, L; Pan, C; Qiu, H; Yang, Y | 1 |
| Erfinanda, L; Gembardt, F; Kaestle, SM; Klein, N; Kuebler, WM; Lei, X; Mertens, M; Nickles, H; Supé, S; Szaszi, K; Walther, T; Wang, L; Yin, J | 1 |
| Corley, A; Fraser, JF; Nataatmadja, M; Passmore, M; Prabowo, S; Russell, FD | 1 |
| Cai, SX; Chen, QH; Chun, P; Guo, FM; Han, JB; He, HL; Hu, SL; Huang, YZ; Liu, L; Qiu, HB; Yang, Y | 1 |
| Cai, S; Chen, Q; He, H; Liu, A; Liu, L; Lu, X; Qiu, H; Yang, Y | 1 |
| Hao, Y; Liu, Y | 1 |
| Cao, Y; Jiang, W; Li, Y; Liang, M; Liu, Y; Ping, F; Xi, C; Xue, Y; Zeng, Z; Zhou, M | 1 |
| Chen, QH; Guo, T; Liu, L; Qiu, HB; Yang, Y; Zhao, MM; Zhu, Y | 1 |
| Ding, HM; Li, HP; Liu, L; Qiu, HB; Wang, L; Yang, Y | 1 |
| Cao, CS; Huang, L; Xiong, HW; Yang, JB; Yin, Q; Zhan, Z | 1 |
| Blair, IA; Dodia, C; Fisher, AB; Greineder, CF; Han, J; Hood, ED; Mesaros, C; Muzykantov, VR; Shuvaev, VV | 1 |
4 review(s) available for angiotensin ii and Lung Injury, Acute
| Article | Year |
|---|---|
The alternative renin-angiotensin system in critically ill patients: pathophysiology and therapeutic implications.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin-Converting Enzyme 2; Critical Illness; Humans; Renin-Angiotensin System | 2023 |
Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; SARS-CoV-2 | 2020 |
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; COVID-19; Humans; Hypertension; JNK Mitogen-Activated Protein Kinases; Lung; MAP Kinase Signaling System; Peptide Fragments; Protective Factors; Receptors, Coronavirus; Renin-Angiotensin System; Risk Factors; SARS-CoV-2; Up-Regulation | 2020 |
[Local renin-angiotensin system disequilibrium and acute lung injury].
Topics: Acute Lung Injury; Angiotensin II; Humans; Lung; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2013 |
25 other study(ies) available for angiotensin ii and Lung Injury, Acute
| Article | Year |
|---|---|
ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Cricetinae; Disease Models, Animal; Female; Humans; Lung; Lung Injury; Male; Mice; Mice, Transgenic; Pulmonary Edema; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Internalization | 2021 |
Fraxinol attenuates LPS-induced acute lung injury by equilibrating ACE-Ang II-AT1R and ACE2-Ang (1-7)-Mas and inhibiting NLRP3.
Topics: Acute Lung Injury; Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Inflammasomes; Lipopolysaccharides; Lung; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Peptidyl-Dipeptidase A | 2022 |
Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Lipopolysaccharides; Mice; Recombinant Proteins; Respiratory Distress Syndrome; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; COVID-19; Escherichia coli; Humans; Lung; Mice; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Respiratory Distress Syndrome; SARS-CoV-2; Sepsis | 2022 |
The Renin-Angiotensin System in Acute Lung Injury.
Topics: Acute Kidney Injury; Acute Lung Injury; Angiotensin II; Humans; Lung; Renin-Angiotensin System | 2022 |
Contribution of angiotensin II in hepatic ischemia /reperfusion induced lung injury: Acute versus chronic usage of captopril.
Topics: Actins; Acute Lung Injury; Angiotensin II; Animals; Captopril; Inflammation; Kupffer Cells; Liver; Lung; Male; Rats; Rats, Wistar; Reperfusion Injury; Respiratory Hypersensitivity; Tumor Necrosis Factor-alpha | 2020 |
Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?
Topics: Acute Lung Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hypertension; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Up-Regulation | 2020 |
Protectin DX promotes epithelial injury repair and inhibits fibroproliferation partly via ALX/PI3K signalling pathway.
Topics: Acute Lung Injury; Alveolar Epithelial Cells; Anaplastic Lymphoma Kinase; Angiotensin II; Animals; Apoptosis; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Inflammation Mediators; Lipopolysaccharides; Mice; Phosphatidylinositol 3-Kinases; Rats | 2020 |
JAK2/STAT3 Pathway Was Associated with the Protective Effects of IL-22 On Aortic Dissection with Acute Lung Injury.
Topics: Acute Lung Injury; Adult; Aged; Angiotensin II; Animals; Aortic Dissection; Apoptosis; Cells, Cultured; Endothelial Cells; Female; Humans; Interleukin-22; Interleukins; Janus Kinase 2; Male; Mice; Mice, Inbred C57BL; Middle Aged; Protein Kinase Inhibitors; Signal Transduction; STAT3 Transcription Factor; Tyrphostins | 2017 |
Vitamin D alleviates lipopolysaccharide‑induced acute lung injury via regulation of the renin‑angiotensin system.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Bronchoalveolar Lavage Fluid; Cells, Cultured; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Lipopolysaccharides; Lung; Male; Microvessels; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Vitamin D | 2017 |
Soluble Epoxide Hydrolase Plays a Vital Role in Angiotensin II-Induced Lung Injury in Mice.
Topics: Acute Lung Injury; Angiotensin II; Animals; Bronchoalveolar Lavage Fluid; Epoxide Hydrolases; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Pneumonia | 2018 |
[ACE2 agonist DIZE alleviates lung injury induced by limb ischemia-reperfusion in mice].
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Hindlimb; Male; Mice; Mice, Inbred ICR; Mice, Transgenic; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Reperfusion Injury | 2018 |
Lipoxin A
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Disease Models, Animal; Humans; Imidazoles; Leucine; Lipopolysaccharides; Lipoxins; Male; Mice; NF-kappa B; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2018 |
Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Drugs, Chinese Herbal; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation; Male; Mice; Mice, Inbred ICR; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2018 |
Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Lipopolysaccharides; Losartan; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome; Vasodilator Agents | 2013 |
Angiotensin-(1-7) protects from experimental acute lung injury.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Electric Impedance; Endothelial Cells; Hemodynamics; Imidazoles; Irbesartan; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Respiratory Mechanics; Tetrazoles | 2013 |
Angiotensin receptors as sensitive markers of acute bronchiole injury after lung transplantation.
Topics: Acute Lung Injury; Adult; Aged; Aged, 80 and over; Angiotensin II; Biomarkers; Bronchioles; Cardiopulmonary Bypass; Female; Humans; Lung Transplantation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Receptor, Angiotensin, Type 2; Time Factors; Young Adult | 2014 |
MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Endothelial Cells; Genetic Therapy; HEK293 Cells; Humans; Lipopolysaccharides; Mesenchymal Stem Cells; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2015 |
Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Bone Marrow Cells; Cells, Cultured; Disease Models, Animal; HEK293 Cells; Humans; Lipopolysaccharides; Lung; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Permeability; Spectroscopy, Near-Infrared; Spleen | 2015 |
Osthole Alleviates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/Angiotensin-(1-7) Axis and Decreasing Inflammation Responses in Rats.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Anti-Inflammatory Agents; Bleomycin; Collagen; Coumarins; Cytokines; Edema; Lung; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Fibrosis; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2016 |
Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Gene Expression Regulation, Enzymologic; Gene Knockdown Techniques; Imidazoles; Lentivirus; Leucine; Lipopolysaccharides; Lung; Male; MAP Kinase Signaling System; NF-kappa B; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction | 2016 |
[Angiotensin II type 2 receptor expression and its modulation in angiotensin II induced acute lung injury in rat].
Topics: Acute Lung Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Losartan; Lung; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger | 2008 |
Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Lipopolysaccharides; Losartan; Lung; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2009 |
[Effect of angiotensin II on the expression of aquaporin 1 in lung of rats following acute lung injury].
Topics: Acute Lung Injury; Angiotensin II; Animals; Aquaporin 1; Disease Models, Animal; Lung; Rats; Rats, Sprague-Dawley | 2010 |
Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.
Topics: Acute Lung Injury; Angiotensin II; Animals; Antibodies, Monoclonal; Antioxidants; Capillary Permeability; Enzyme Inhibitors; Glycerophosphates; Human Umbilical Vein Endothelial Cells; Humans; Immunoglobulin G; Lipopolysaccharides; Liposomes; Lung; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Phospholipases A; Platelet Endothelial Cell Adhesion Molecule-1; Reactive Oxygen Species; Streptavidin; Tissue Distribution; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2012 |